Sentry Investment Management LLC lowered its stake in HCP, Inc. (NYSE:HCP) by 6.0% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 19,834 shares of the real estate investment trust’s stock after selling 1,266 shares during the period. Sentry Investment Management LLC’s holdings in HCP were worth $620,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HCP. Mirador Capital Partners LP boosted its position in HCP by 2.2% in the first quarter. Mirador Capital Partners LP now owns 8,619 shares of the real estate investment trust’s stock valued at $270,000 after buying an additional 189 shares during the period. Utah Retirement Systems boosted its position in HCP by 1.7% in the first quarter. Utah Retirement Systems now owns 116,607 shares of the real estate investment trust’s stock valued at $3,647,000 after buying an additional 1,900 shares during the period. Legal & General Group Plc boosted its position in HCP by 5.0% in the first quarter. Legal & General Group Plc now owns 3,261,911 shares of the real estate investment trust’s stock valued at $102,030,000 after buying an additional 155,082 shares during the period. Accident Compensation Corp boosted its position in HCP by 13.1% in the first quarter. Accident Compensation Corp now owns 60,421 shares of the real estate investment trust’s stock valued at $1,890,000 after buying an additional 7,000 shares during the period. Finally, Eliot Finkel Investment Counsel LLC purchased a new position in HCP during the first quarter valued at approximately $2,702,000. Institutional investors own 88.94% of the company’s stock.

Institutional Ownership by Quarter for HCP (NYSE:HCP)

HCP, Inc. (HCP) traded up 1.06% during mid-day trading on Friday, reaching $32.51. 4,214,558 shares of the company traded hands. HCP, Inc. has a 52-week low of $27.61 and a 52-week high of $36.82. The stock has a market capitalization of $15.23 billion, a PE ratio of 15.68 and a beta of 0.42. The firm’s 50-day moving average is $31.28 and its 200 day moving average is $30.80.

HCP (NYSE:HCP) last released its quarterly earnings data on Tuesday, May 2nd. The real estate investment trust reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.03. The firm had revenue of $492.16 million during the quarter, compared to the consensus estimate of $514.82 million. HCP had a net margin of 41.38% and a return on equity of 12.39%. The firm’s revenue was down 5.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.69 earnings per share. On average, equities research analysts expect that HCP, Inc. will post $1.45 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 23rd. Shareholders of record on Monday, May 8th were issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a yield of 4.55%. The ex-dividend date of this dividend was Thursday, May 4th. HCP’s dividend payout ratio is presently 72.20%.

TRADEMARK VIOLATION NOTICE: This piece was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at

Several research analysts have recently issued reports on HCP shares. Raymond James Financial, Inc. upgraded shares of HCP from an “underperform” rating to an “outperform” rating and set a $35.00 target price for the company in a report on Wednesday. Jefferies Group LLC restated a “hold” rating and issued a $32.00 target price on shares of HCP in a report on Friday, May 12th. Evercore ISI cut shares of HCP from an “in-line” rating to an “underperform” rating in a report on Monday, April 24th. Mitsubishi UFJ Financial Group started coverage on shares of HCP in a report on Friday, April 21st. They issued a “hold” rating and a $32.00 target price for the company. Finally, Mizuho cut shares of HCP from a “buy” rating to a “neutral” rating and lowered their target price for the company from $34.00 to $32.00 in a report on Tuesday, April 11th. One research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $33.18.

In other HCP news, insider Thomas Klaritch sold 2,651 shares of HCP stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $31.53, for a total value of $83,586.03. Following the completion of the transaction, the insider now owns 176,830 shares of the company’s stock, valued at $5,575,449.90. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.22% of the company’s stock.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Want to see what other hedge funds are holding HCP? Visit to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.